Synthetic peptides as vaccines
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 4 (4) , 449-453
- https://doi.org/10.1016/s0952-7915(06)80037-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Induction of Broadly Cross-Reactive Cytotoxic T Cells Recognizing an HIV-1 Envelope DeterminantScience, 1992
- Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cellsEuropean Journal of Immunology, 1991
- Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenesNature, 1991
- Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptideEuropean Journal of Immunology, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigenEuropean Journal of Immunology, 1991
- In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccineNature, 1989
- Expression of Shiga toxin epitopes in E. coli immunological characterizationImmunology Letters, 1989
- Synthetic peptides: a next generation of vaccines?Immunology Today, 1987
- Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.The Journal of Experimental Medicine, 1983